Craft

Sucampo Pharmaceuticals

Revenue

$230.1 M

FY, 2016

Sucampo Pharmaceuticals Summary

Company summary

Overview
Sucampo Pharmaceuticals is a global biopharmaceutical company focused on innovative research and development of proprietary drugs to treat gastrointestinal, ophthalmic, and oncology-based inflammatory disorders. Sucampo has a marketed product - AMITIZA® - and a pipeline including lifecycle management and clinical development programs.
Type
Subsidiary
Status
Active
Founded
1996
HQ
Rockville, MD, US | view all locations
Website
http://sucampo.com
Cybersecurity rating
Sectors

LocationsView all

7 locations detected

  • Rockville, MD HQ

    United States

    805 King Farm Blvd #550

  • Chiyoda, Tokyo

    Japan

    NBF Hibiya Building, 10th Floor 1-1-7 Uchisaiwaicho

  • Chuo Ward, Hyogo Prefecture

    Japan

    Kobe Hybrid Business Center, 3rd Floor 6-7-6 Minatojima Minamimachi, Chuo-ku, Kobe City

  • Kita Ward, Osaka Prefecture

    Japan

    Nishiumeda MID Building, 4th Floor 2-2-16 Sonezakishinchi

  • Sanda-shi, Hyōgo-ken

    Japan

    4-1 Techno-Park

  • Zug, Zug

    Switzerland

    22 Baarerstrasse

and 1 others

Sucampo Pharmaceuticals Financials

Summary financials

Revenue (Q3, 2017)
$61.3M
Gross profit (Q3, 2017)
$43.8M
Net income (Q3, 2017)
$10.4M
Cash (Q3, 2017)
$75.0M
EBIT (Q3, 2017)
$21.2M

Footer menu